Belite Bio
BLTE154.0102.90% ( -4.600 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Belite Bio(BLTE) predict that the EBIT is -32.68 M (-110.6%), Miss estimate;the EPS is -0.68 (-51.11%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.03B110.63%
-0.03B74.86%
-0.01B35.77%
EPSMiss expectations
-0.6851.11%
-0.654345.40%
-0.02575.71%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf